{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:14:50Z","timestamp":1777616090644,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011780","name":"Johns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health","doi-asserted-by":"publisher","award":["T32MH103210"],"award-info":[{"award-number":["T32MH103210"]}],"id":[{"id":"10.13039\/100011780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011780","name":"Johns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health","doi-asserted-by":"publisher","award":["T32DA007292"],"award-info":[{"award-number":["T32DA007292"]}],"id":[{"id":"10.13039\/100011780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.addbeh.2019.01.020","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T01:58:30Z","timestamp":1547690310000},"page":"14-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Challenges on the road to recovery: Exploring attitudes and experiences of clients in a community-based buprenorphine program in Baltimore City"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5103-5148","authenticated-orcid":false,"given":"C.","family":"Truong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dejman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Marshall-Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tormohlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Agus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.addbeh.2019.01.020_bb0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research","volume":"28","author":"Amato","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.addbeh.2019.01.020_bb0010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1360-0443.2001.9656834.x","article-title":"A meta\u2212analysis comparing buprenorphine to methadone for treatment of opiate dependence","volume":"96","author":"Barnett","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0015","unstructured":"Behavioral Health Leadership Institute (BHLI). Project connections buprenorphine program: program and Client summary 2010\u20132016. http:\/\/mail.bhli.org\/pdf\/BHLIBupeProgramReportSept2016.pdf. Published September 2016."},{"issue":"1","key":"10.1016\/j.addbeh.2019.01.020_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1940-0640-7-3","article-title":"Return to drug use and overdose after release from prison: A qualitative study of risk and protective factors","volume":"7","author":"Binswanger","year":"2012","journal-title":"Addiction Science & Clinical Practice"},{"issue":"2","key":"10.1016\/j.addbeh.2019.01.020_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prisone\u2014A high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.addbeh.2019.01.020_bb0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cpr.2005.11.005","article-title":"Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: A review","volume":"26","author":"Bradizza","year":"2006","journal-title":"Clinical Psychology Review"},{"issue":"1","key":"10.1016\/j.addbeh.2019.01.020_bb0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1360-0443.1998.931738.x","article-title":"RESEARCH REPORT a meta\u2212analysis of predictors of continued drug use during and after treatment for opiate addiction","volume":"93","author":"Brewer","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0040","series-title":"Understanding the Epidemic","author":"Centers for Disease Control and Prevention (CDC)","year":"2017"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0045","series-title":"U.S drug overdose deaths continue to rise; increase fueled by synthetic opioids","author":"Centers for Disease Control and Prevention (CDC)","year":"2018"},{"issue":"2","key":"10.1016\/j.addbeh.2019.01.020_bb0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"issue":"2","key":"10.1016\/j.addbeh.2019.01.020_bb0060","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11469-016-9719-6","article-title":"Stigma and social support in pharmaceutical opioid treatment populations: A scoping review","volume":"15","author":"Cooper","year":"2017","journal-title":"International Journal of Mental Health and Addiction"},{"issue":"3","key":"10.1016\/j.addbeh.2019.01.020_bb0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jsat.2011.05.001","article-title":"Risk of drug-related mortality during periods of transition in methadone maintenance treatment: A cohort study","volume":"41","author":"Cousins","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0070","series-title":"Qualitative methodology for International public health","author":"Dahlgren","year":"2007"},{"issue":"1","key":"10.1016\/j.addbeh.2019.01.020_bb0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/ADM.0000000000000004","article-title":"A novel community-based buprenorphine program: Client description and initial outcomes","volume":"8","author":"Daniels","year":"2014","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.addbeh.2019.01.020_bb0080","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.addbeh.2009.11.001","article-title":"Social desirability biases in self-reported alcohol consumption and harms","volume":"35","author":"Davis","year":"2010","journal-title":"Addictive Behaviors"},{"issue":"6","key":"10.1016\/j.addbeh.2019.01.020_bb0085","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.addbeh.2011.01.004","article-title":"Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness","volume":"36","author":"Deering","year":"2011","journal-title":"Addictive Behaviors"},{"issue":"7","key":"10.1016\/j.addbeh.2019.01.020_bb0090","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1360-0443.2011.03400.x","article-title":"Employment\u2212based reinforcement of adherence to depot naltrexone in unemployed opioid\u2212dependent adults: A randomized controlled trial","volume":"106","author":"Everly","year":"2011","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.addbeh.2019.01.020_bb0095","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","article-title":"The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013","volume":"54","author":"Florence","year":"2016","journal-title":"Medical Care"},{"issue":"2","key":"10.1016\/j.addbeh.2019.01.020_bb0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nedt.2003.10.001","article-title":"Qualitative content analysis in nursing research: Concepts, procedures and measures to achieve trustworthiness","volume":"24","author":"Graneheim","year":"2004","journal-title":"Nurse Education Today"},{"issue":"4","key":"10.1016\/j.addbeh.2019.01.020_bb0105","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1176\/appi.ps.201700211","article-title":"Leveraging behavioral health expertise: Practices and potential of the project ECHO approach to virtually integrating care in underserved areas","volume":"69","author":"Hager","year":"2018","journal-title":"Psychiatric Services"},{"issue":"8","key":"10.1016\/j.addbeh.2019.01.020_bb0110","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","article-title":"Opioid substitution therapy: Lowering the treatment thresholds","volume":"161","author":"Kourounis","year":"2016","journal-title":"Drug & Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2017.06.009","article-title":"Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample","volume":"178","author":"Krawczyk","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0130","first-page":"1","article-title":"Overcoming medication stigma in peer recovery: A new paradigm","author":"Krawczyk","year":"2018","journal-title":"Substance Abuse"},{"issue":"12","key":"10.1016\/j.addbeh.2019.01.020_bb0135","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1377\/hlthaff.2017.0890","article-title":"Only one in twenty justice-referred adults in specialty treatment for opioid use receive Methadone or Buprenorphine","volume":"36","author":"Krawczyk","year":"2017","journal-title":"Health Affairs (Project Hope)"},{"issue":"6","key":"10.1016\/j.addbeh.2019.01.020_bb0140","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1176\/ps.2007.58.6.773","article-title":"Understanding and preventing criminal recidivism among adults with psychotic disorders","volume":"58","author":"Lamberti","year":"2007","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0145","series-title":"Dedoose [Web-based application]","author":"Lieber","year":"2018"},{"issue":"1","key":"10.1016\/j.addbeh.2019.01.020_bb0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-7517-9-8","article-title":"Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment","volume":"9","author":"Marchand","year":"2012","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0155","unstructured":"Maryland Department of Health (MDH). (2017). Drug- and Alcohol-Related Intoxication Deaths in Maryland, https:\/\/bha.health.maryland.gov\/OVERDOSE_PREVENTION\/Documents\/Maryland%202016%20Overdose%20Annual%20report.pdf"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0160","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0165","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. (2014) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2014, Issue 2. Art. No.: CD002207. DOI: https:\/\/doi.org\/10.1002\/14651858.CD002207.pub4.","DOI":"10.1002\/14651858.CD002207.pub4"},{"issue":"7","key":"10.1016\/j.addbeh.2019.01.020_bb0170","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1176\/appi.ps.56.7.840","article-title":"Incarceration associated with homelessness, mental disorder, and co-occurring substance abuse","volume":"56","author":"McNiel","year":"2005","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0175","first-page":"1049","article-title":"Human immunodeficiency virus seroconversion among intravenous drug users in-and out-of-treatment: An 18-month prospective follow-up","volume":"6","author":"Metzger","year":"1993","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jsat.2015.05.005","article-title":"Buprenorphine treatment and 12-step meeting attendance: Conflicts, compatibilities, and patient outcomes","volume":"57","author":"Monico","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0185","series-title":"Overdose Death rates","author":"National Institute on Drug Abuse (NIDA)","year":"2017"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drugalcdep.2015.08.037","article-title":"The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting","volume":"156","author":"Nolan","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0195","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.addbeh.2014.09.021","article-title":"Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: A discrete survival and growth mixture model","volume":"41","author":"Northrup","year":"2015","journal-title":"Addictive Behaviors"},{"issue":"3","key":"10.1016\/j.addbeh.2019.01.020_bb0200","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jsat.2011.12.008","article-title":"Addiction treatment-related employment barriers: The impact of methadone maintenance","volume":"43","author":"Richardson","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.addbeh.2019.01.020_bb0205","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2648.2006.03727.x","article-title":"Validity, trustworthiness and rigor: Quality and the idea of qualitative research","volume":"53","author":"Rolfe","year":"2006","journal-title":"Journal of Advanced Nursing"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0210","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.09.017","article-title":"Linking patients with buprenorphine treatment in primary care: Predictors of engagement","volume":"181","author":"Simon","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.addbeh.2019.01.020_bb0215","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s002130100917","article-title":"How does stress increase risk of drug abuse and relapse?","volume":"158","author":"Sinha","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0220","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.addbeh.2019.01.020_bb0230","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","article-title":"Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","volume":"174","author":"Tsui","year":"2014","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0235","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajp.2014.03.009","article-title":"Behavioral Health Homes: An opportunity to address healthcare inequities in people with serious mental illness","volume":"10","author":"Viron","year":"2014","journal-title":"Asian Journal of Psychiatry"},{"issue":"22","key":"10.1016\/j.addbeh.2019.01.020_bb0240","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014Tackling the opioid-overdose epidemic","volume":"370","author":"Voklow","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.addbeh.2019.01.020_bb0245","series-title":"Narcotics Anonymous and the Pharmacotherapeutic Treatment of Opioid Addiction in the United States","author":"White","year":"2011"},{"issue":"4","key":"10.1016\/j.addbeh.2019.01.020_bb0250","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jsat.2011.09.013","article-title":"The effect of social desirability on reported motivation, substance use severity, and treatment attendance","volume":"42","author":"Zemore","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.addbeh.2019.01.020_bb0255","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014","volume":"108","author":"Zibbell","year":"2018","journal-title":"American Journal of Public Health"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460318308360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460318308360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:35:17Z","timestamp":1759689317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460318308360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":48,"alternative-id":["S0306460318308360"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2019.01.020","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges on the road to recovery: Exploring attitudes and experiences of clients in a community-based buprenorphine program in Baltimore City","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2019.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}